| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.36▲ | 1.34▲ | 1.34▲ | 1.35▼ | 1.44▼ |
| MA10 | 1.34▲ | 1.35▲ | 1.34▲ | 1.34▲ | 1.49▼ |
| MA20 | 1.35▲ | 1.34▲ | 1.34▲ | 1.43▼ | 1.51▼ |
| MA50 | 1.35▲ | 1.41▼ | 1.42▼ | 1.49▼ | N/A |
| MA100 | 1.45▼ | 1.50▼ | 1.50▼ | 1.49▼ | N/A |
| MA200 | 1.52▼ | 1.53▼ | 1.54▼ | 1.12▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.007▲ | 0.008▲ | -0.009▼ | 0.114▲ |
| RSI | 53.377▲ | 51.144▲ | 50.781▲ | 44.511▼ | 34.485▼ |
| STOCH | 72.917 | 43.304 | 45.420 | 50.721 | 41.293 |
| WILL %R | -18.750▲ | -18.750▲ | -16.667▲ | -77.049▼ | -63.291 |
| CCI | 40.230 | 57.528 | 60.494 | -37.320 | -102.357▼ |
| CDL | $JUNS Harami Candlestick Pattern Detected | Set Alert |
|
Tuesday, November 11, 2025 07:38 AM
Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based therapeutic platform targeting neuroinflammation and mitochondrial ...
|
|
Monday, October 27, 2025 05:38 AM
Financing designed to support Phase 2 Parkinson’s trial and accelerate Nugevia™ product line growth Jupiter, FL, Oct. 27, 2025 (GLOBE NEWSWIRE) ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.33 | 1.38 | 1.306 | 1.34 | 49,400 |
| 13/11/25 | 1.36 | 1.36 | 1.2906 | 1.31 | 27,267 |
| 12/11/25 | 1.34 | 1.38 | 1.33 | 1.38 | 62,900 |
| 11/11/25 | 1.38 | 1.38 | 1.30 | 1.33 | 48,000 |
| 10/11/25 | 1.33 | 1.38 | 1.27 | 1.37 | 87,320 |
| 07/11/25 | 1.34 | 1.36 | 1.308 | 1.33 | 90,500 |
| 06/11/25 | 1.35 | 1.375 | 1.311 | 1.36 | 69,200 |
| 05/11/25 | 1.27 | 1.36 | 1.20 | 1.36 | 552,916 |
| 04/11/25 | 1.35 | 1.375 | 1.23 | 1.25 | 76,010 |
| 03/11/25 | 1.38 | 1.40 | 1.305 | 1.32 | 120,000 |
|
|
||||
|
|
||||
|
|